Intrinsically photosensitive retinal ganglion cell
Intrinsically photosensitive retinal ganglion cells (ipRGCs) are a type of retinal ganglion cell that are directly sensitive to light. They play a crucial role in non-image-forming visual functions, such as the regulation of circadian rhythms, the pupillary light reflex, and other physiological responses to ambient light levels.
Structure[edit]
ipRGCs are unique among retinal ganglion cells because they contain the photopigment melanopsin, which allows them to respond directly to light. These cells are located in the inner retina, and their dendrites extend into the inner plexiform layer.
Melanopsin[edit]
Melanopsin is a photopigment found in ipRGCs that is sensitive to blue light, with a peak sensitivity around 480 nm. This pigment is crucial for the light-sensing capabilities of ipRGCs, enabling them to perform their non-image-forming functions.
Function[edit]
ipRGCs are involved in several key physiological processes:
Circadian Rhythms[edit]
ipRGCs project to the suprachiasmatic nucleus (SCN) of the hypothalamus, which is the primary circadian pacemaker in mammals. By conveying information about ambient light levels, ipRGCs help synchronize the body's internal clock with the external environment.
Pupillary Light Reflex[edit]
The pupillary light reflex is another important function of ipRGCs. These cells send signals to the pretectal area of the brain, which in turn controls the constriction of the pupil in response to light.
Other Functions[edit]
ipRGCs also contribute to mood regulation and sleep patterns by influencing the release of melatonin and other hormones. They may also play a role in seasonal affective disorder and other light-related mood disorders.
Development[edit]
ipRGCs develop early in the retina and are among the first retinal cells to become functional. Their development is crucial for the establishment of circadian rhythms and other light-dependent physiological processes.
Clinical Significance[edit]
Dysfunction of ipRGCs can lead to various disorders, including circadian rhythm sleep disorders and abnormal pupillary responses. Research into ipRGCs is ongoing, with potential implications for treating these and other conditions.
.png){kind=link}
